Skip to main content
. Author manuscript; available in PMC: 2016 May 17.
Published in final edited form as: HIV/AIDS Res Treat. 2015 Nov 17;2015(SE3):S1–S8. doi: 10.17140/HARTOJ-SE-3-101

Table 1.

Descriptive characteristics of the sample population at baseline (N=120).

Characteristics <50 years old
n=90 (75.0%)
≥50 years old
n=30 (25.0%)
Overall
N=120
Ethnicity (%)
 Non-African American 5(5.6%) 3(10.0%) 8(6.7%)
  African American 85(94.4%) 27(90.0%) 112(93.3%)
Sexual Identity
  LGBT or unsure 22(24.4%) 6(20.0%) 28(23.3%)
   Heterosexual 68(75.6%) 24(80.0%) 92(76.7%)
    Single 57(64.0%) 29(96.7%) 86(72.3%)**
   Partnered 32(36.0%) 1(3.3%) 33(27.7%)
Education Level
 < High School Grad 68(75.6%) 21(70.0%) 89(74.2%)
 ≥ High School grad 22(24.4%) 9(30.0%) 31(25.8%)
  Unemployed 74(82.2%) 25(83.3%) 99(82.5%)
   Employed 16(17.8%) 5(16.7%) 21(17.5%)
Annual Incomeb
   ≤ $10,000 59(67.0%) 19(67.9%) 78(67.2%)
   > $10,000 29(33.0%) 9(32.1%) 38(32.8%)
M(SD) Range M(SD) Range M(SD) Range
Age, years 39.5(6.8) 18–49 55.7(4.2) 50–67 43.6(9.4) 18–67
Duration of HIVa 8.9(5.9) 1–26 9.5(5.8) 1–22 9.1(5.8) 1–26
Duration on ART 5.2(3.9) 0–17 6.3(4.8) 0–16 5.5(4.2) 0–17
  (ART years >5) 40(44.4%) 16(53.3%) 56(46.7%)
Adherence: AGAS 20.3(3.3) 12–25 20.9(2.5) 15–25 20.5(3.2) 12–25
  (AGAS as a%) 81.2(13.3) 48–100 83.7(10.1) 60–100 81.8(12.7) 48–100
Adherence: MEMS 72.1(32.9) 0–100 79.6(32.6) 8.3–100 74.0(32.9) 0–100
 (Adherence ≥95%) 32(35.6%) 16(53.3%) 48(40.0%)
CD4 (%) 18.6(11.2) 1–61 23.3(11.0) 7–45 19.7(11.3) 1–61*
Viral Load (log) 2.6(1.1) 1.7–5.46 2.3(0.8) 1.7–4.93 2.5(1.0) 1.7–5.46
  V load (log) ≤2.60 56(62.2%) 24(80.0%) 80(66.7%)
 Stigma, Personalc 45.2(10.5) 25–72 45.9(11.1) 24–68 45.4(10.6) 24–72
*

p<.05;

**

p< .01;

***

p<.001;

a

1 missing;

b

4 missing;

c

3 missing